C Heidemann1, Y Du2, R Paprott2, M Haftenberger2, W Rathmann3, C Scheidt-Nave2. 1. Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany. heidemannc@rki.de. 2. Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany. 3. Institute for Biometrics and Epidemiology, German Diabetes Centre, Leibniz Institute for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
Abstract
AIMS: Nationally representative data on temporal changes in the prevalence of diagnosed diabetes, as well as undiagnosed diabetes and prediabetes, have been lacking in Germany as in most other European countries. We aimed to fill this gap using data from nationwide examination surveys of German adults. METHODS: The study population comprised 18-79-year-old participants from the German Health Interview and Examination Surveys in 1997-1999 (GNHIES98, n = 6655) and 2008-2011 (DEGS1, n = 7017). Participants were classified as having diagnosed diabetes based on self-reported physician-diagnosed diabetes or the use of anti-diabetes agents. Among those without diagnosed diabetes, HbA1c measures were used to define undiagnosed diabetes [≥ 48 mmol/mol (≥ 6.5%)] or prediabetes [39-47 mmol/mol (5.7-6.4%)]. RESULTS: Although the age- and sex-standardized prevalence of total diabetes remained stable between 1997-1999 at 9.3% (95% CI 8.3-10.5%) and 2008-2011 at 9.2% (8.3-10.3%), the prevalence of diagnosed diabetes increased from 5.6% (4.9-6.3%) to 7.2% (6.5-8.0%), whereas the prevalence of undiagnosed diabetes decreased from 3.8% (3.1-4.6%) to 2.0% (1.5-2.7%), resulting in a decreased proportion of undiagnosed diabetes (40.9% vs. 21.7%). Over the same period, the prevalence of prediabetes decreased from 27.7% (25.6-29.8%) to 20.8% (18.2-23.7%). Observed temporal changes were not explained by changes in BMI, sport activity and educational level. CONCLUSIONS: The two nationwide surveys indicate a shift from undiagnosed to diagnosed diabetes. However, the unchanged prevalence of total diabetes and the considerably high proportion of prediabetes strongly call for a continued and concerted effort in diabetes prevention among German adults.
AIMS: Nationally representative data on temporal changes in the prevalence of diagnosed diabetes, as well as undiagnosed diabetes and prediabetes, have been lacking in Germany as in most other European countries. We aimed to fill this gap using data from nationwide examination surveys of German adults. METHODS: The study population comprised 18-79-year-old participants from the German Health Interview and Examination Surveys in 1997-1999 (GNHIES98, n = 6655) and 2008-2011 (DEGS1, n = 7017). Participants were classified as having diagnosed diabetes based on self-reported physician-diagnosed diabetes or the use of anti-diabetes agents. Among those without diagnosed diabetes, HbA1c measures were used to define undiagnosed diabetes [≥ 48 mmol/mol (≥ 6.5%)] or prediabetes [39-47 mmol/mol (5.7-6.4%)]. RESULTS: Although the age- and sex-standardized prevalence of total diabetes remained stable between 1997-1999 at 9.3% (95% CI 8.3-10.5%) and 2008-2011 at 9.2% (8.3-10.3%), the prevalence of diagnosed diabetes increased from 5.6% (4.9-6.3%) to 7.2% (6.5-8.0%), whereas the prevalence of undiagnosed diabetes decreased from 3.8% (3.1-4.6%) to 2.0% (1.5-2.7%), resulting in a decreased proportion of undiagnosed diabetes (40.9% vs. 21.7%). Over the same period, the prevalence of prediabetes decreased from 27.7% (25.6-29.8%) to 20.8% (18.2-23.7%). Observed temporal changes were not explained by changes in BMI, sport activity and educational level. CONCLUSIONS: The two nationwide surveys indicate a shift from undiagnosed to diagnosed diabetes. However, the unchanged prevalence of total diabetes and the considerably high proportion of prediabetes strongly call for a continued and concerted effort in diabetes prevention among German adults.
Authors: Jonas D Finger; Markus A Busch; Yong Du; Christin Heidemann; Hildtraud Knopf; Ronny Kuhnert; Thomas Lampert; Gert B M Mensink; Hannelore K Neuhauser; Angelika Schaffrath Rosario; Christa Scheidt-Nave; Anja Schienkiewitz; Julia Truthmann; Bärbel-Maria Kurth Journal: Dtsch Arztebl Int Date: 2016-10-21 Impact factor: 5.594
Authors: Maria Narres; Heiner Claessen; Tatjana Kvitkina; Michael Koch; Lars Christian Rump; Thomas Weinreich; Andrea Icks Journal: Diabetologia Date: 2019-12-21 Impact factor: 10.122
Authors: Marsha L Tracey; Michael Gilmartin; Kate O'Neill; Anthony P Fitzgerald; Sheena M McHugh; Claire M Buckley; Ronan J Canavan; Patricia M Kearney Journal: BMC Public Health Date: 2016-02-09 Impact factor: 3.295
Authors: Julia Truthmann; Gert B M Mensink; Anja Bosy-Westphal; Christa Scheidt-Nave; Anja Schienkiewitz Journal: PLoS One Date: 2016-11-23 Impact factor: 3.240
Authors: Kate Junker; Claire M Buckley; Seán R Millar; Sinéad Flynn; Janas M Harrington; Patricia M Kearney; Ivan J Perry Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240
Authors: Stephanie H Read; Joannes J Kerssens; David A McAllister; Helen M Colhoun; Colin M Fischbacher; Robert S Lindsay; Rory J McCrimmon; John A McKnight; John R Petrie; Naveed Sattar; Sarah H Wild Journal: Diabetologia Date: 2016-07-28 Impact factor: 10.122
Authors: Rebecca Paprott; Kristin Mühlenbruch; Gert B M Mensink; Silke Thiele; Matthias B Schulze; Christa Scheidt-Nave; Christin Heidemann Journal: BMJ Open Diabetes Res Care Date: 2016-11-21